. . . . . . . . . "empliciti is indicated in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor empliciti is a slamf7 directed immunostimulatory antibody indicated in 1 1" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "Dz24KF/bcE1UflGfyoa3bDg7OryN9nzpuTixUHfd9K1ZTDt7I/DAym4UqaYg8lHQ5XRkJFvEx1qxOpA4W/NGm0I3y6lTjcpOQTyQ1QJ1PiwkknUf60rwCUws0lc7oNnALCLS4Bb+OPRR7vxGryo5XBJ/yjfz/esM/TYwJbm4Nfk=" . . "2021-06-12T12:50:40.162+02:00"^^ . . . . .